Literature DB >> 15790526

Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?

Kathleen A Maguire-Zeiss1, Douglas W Short, Howard J Federoff.   

Abstract

The etiology of Parkinson's disease (PD) is presently unknown. The unifying hallmark of disease is depletion of dopamine and loss of nigrostriatal dopamine neurons. Familial and sporadic forms of the disease are described. The familial mutations occur within alpha-synuclein and molecules involved in protein degradation and mitochondrial function. Sporadic PD is thought to involve the interplay of genetic and environmental factors. Despite disparate initiating triggers, a convergent pathobiologic model for this common neurodegenerative disease has been proposed. Likely players have emerged that may form the basis for this common pathway model of disease. In this review, we examine the role of three most implicated PD pathogenic conspirators: synuclein, dopamine and oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790526     DOI: 10.1016/j.molbrainres.2004.09.014

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  37 in total

Review 1.  Mechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylation.

Authors:  Elizabeth A Sabens Liedhegner; Xing-Huang Gao; John J Mieyal
Journal:  Antioxid Redox Signal       Date:  2012-01-06       Impact factor: 8.401

2.  The association between Mediterranean diet adherence and Parkinson's disease.

Authors:  Roy N Alcalay; Yian Gu; Helen Mejia-Santana; Lucien Cote; Karen S Marder; Nikolaos Scarmeas
Journal:  Mov Disord       Date:  2012-02-07       Impact factor: 10.338

3.  Levodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of Parkinson's disease.

Authors:  Elizabeth A Sabens Liedhegner; Kelly M Steller; John J Mieyal
Journal:  Chem Res Toxicol       Date:  2011-08-22       Impact factor: 3.739

Review 4.  Oxidative and inflammatory pathways in Parkinson's disease.

Authors:  Rebecca L Miller; Marilyn James-Kracke; Grace Y Sun; Albert Y Sun
Journal:  Neurochem Res       Date:  2008-03-25       Impact factor: 3.996

5.  Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance.

Authors:  Li Rebekah Feng; Kathleen A Maguire-Zeiss
Journal:  Neurotox Res       Date:  2011-07-07       Impact factor: 3.911

6.  A loss in cellular protein partners promotes α-synuclein aggregation in cells resulting from oxidative stress.

Authors:  Yuanjian Guo; Suzanne Scarlata
Journal:  Biochemistry       Date:  2013-05-21       Impact factor: 3.162

Review 7.  Critical Roles of Glutaredoxin in Brain Cells-Implications for Parkinson's Disease.

Authors:  Olga Gorelenkova Miller; John J Mieyal
Journal:  Antioxid Redox Signal       Date:  2018-01-05       Impact factor: 8.401

8.  Prospective study of dietary pattern and risk of Parkinson disease.

Authors:  Xiang Gao; Honglei Chen; Teresa T Fung; Giancarlo Logroscino; Michael A Schwarzschild; Frank B Hu; Alberto Ascherio
Journal:  Am J Clin Nutr       Date:  2007-11       Impact factor: 7.045

9.  Oxidation of survival factor MEF2D in neuronal death and Parkinson's disease.

Authors:  Li Gao; Hua She; Wenming Li; Jin Zeng; Jinqiu Zhu; Dean P Jones; Zixu Mao; Guodong Gao; Qian Yang
Journal:  Antioxid Redox Signal       Date:  2014-02-03       Impact factor: 8.401

10.  Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.

Authors:  Maria Xilouri; Tereza Vogiatzi; Kostas Vekrellis; David Park; Leonidas Stefanis
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.